Body Recomposition
Peptides that shift body composition by reducing visceral fat, increasing lean mass, or improving metabolic partitioning. These agents primarily work through GH/IGF 1 pathways or incretin driven fat loss.
5-Amino-1MQ
Improved metabolic efficiency and fat-loss signaling
Unknown safety
Plausibly effective
Updated October 18, 2026
5-Amino-1MQ
Improved metabolic efficiency and fat-loss signaling
Unknown safety
Plausibly effective
Updated October 18, 2026
5-Amino-1MQ
Improved metabolic efficiency and fat-loss signaling
Unknown safety
Plausibly effective
Updated October 18, 2026
CJC1295NoDAC + Ipamorelin
increases pulsatile GH release to support muscle anabolism and recovery.
Probably safe
Probably effective
Updated October 12, 2026
CJC1295NoDAC + Ipamorelin
increases pulsatile GH release to support muscle anabolism and recovery.
Probably safe
Probably effective
Updated October 12, 2026
CJC1295NoDAC + Ipamorelin
increases pulsatile GH release to support muscle anabolism and recovery.
Probably safe
Probably effective
Updated October 12, 2026
Retatrutide
multi-agonist producing profound appetite suppression and fat loss.
Safe
Effective
Updated October 14, 2026
Retatrutide
multi-agonist producing profound appetite suppression and fat loss.
Safe
Effective
Updated October 14, 2026
Retatrutide
multi-agonist producing profound appetite suppression and fat loss.
Safe
Effective
Updated October 14, 2026
Tesamorelin
stimulates GH axis to reduce visceral fat and improve body composition.
Safe
Effective
Updated October 14, 2026
Tesamorelin
stimulates GH axis to reduce visceral fat and improve body composition.
Safe
Effective
Updated October 14, 2026
Tesamorelin
stimulates GH axis to reduce visceral fat and improve body composition.
Safe
Effective
Updated October 14, 2026
Tesamorelin + Ipamorelin
combined GH-releasing effect for enhanced anabolic and performance support.
Probably safe
Effective
Updated September 24, 2026
Tesamorelin + Ipamorelin
combined GH-releasing effect for enhanced anabolic and performance support.
Probably safe
Effective
Updated September 24, 2026
Tesamorelin + Ipamorelin
combined GH-releasing effect for enhanced anabolic and performance support.
Probably safe
Effective
Updated September 24, 2026
Tirzepatide
reduces appetite and increases weight loss via GLP-1/GIP agonism.
Safe
Effective
Updated October 14, 2026
Tirzepatide
reduces appetite and increases weight loss via GLP-1/GIP agonism.
Safe
Effective
Updated October 14, 2026
Tirzepatide
reduces appetite and increases weight loss via GLP-1/GIP agonism.
Safe
Effective
Updated October 14, 2026